Comparison of two drugs for pain free time in hand surgeries.

Comparative study between Dexmedetomidine and Dexamethasone as an adjuvant to Bupivacaine in supraclavicular brachial plexus block in upper limb surgeries.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048083

Enrollment

Registered

2022-12-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S523- Fracture of shaft of radius Health Condition 2: S521- Fracture of upper end of radius

Interventions

Intervention1: Suraclavicular brachial plexus block: Patients divided into 2groups. Group DX and group DM.All patients underwent ultrasound guidance supraclavicular brachial plexus block with 20ml of

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Forearm fracture, with ASA status l , ll and weight 50-70kg to beincluded in the study.

Exclusion criteria

Exclusion criteria: Patients refusal, Infection at the site of block, coagulopathy or bleeding disorders, alcohol or drug abuse, patients with psychiatric disorders, known allergies to any drug to be used, failed block

Design outcomes

Primary

Measure	Time frame
Dexmedetomidine provides prolonged duration of analgesia than dexamethasoneTimepoint: 0, 1, 2, 4,6,12,24 hours after completion of injection	—

Secondary

Measure	Time frame
Onset of sensory and motor block to be observedTimepoint: 1,2,4,6,7,10, 12,15,20,25 minutes	—

Countries

India

Contacts

Public ContactMadhusmita Kundu

VIMSAR, Burla

madhusmitakundu777@gmail.com8917541089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026